AbCellera Biologics Inc vs Datadog Inc — how do they compare? AbCellera Biologics Inc trades at $9.07 (market cap $2.99B), while Datadog Inc trades at $244.44 (market cap $88.61B). The key difference: Datadog Inc is far larger — about 29.6× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Datadog Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | DDOG | |
|---|---|---|
Market Cap | $2.99B | $88.61B |
Sector | Health | Technology |
52-Week High | $9.76 | $288.15 |
52-Week Low | $2.78 | $102.62 |
Enterprise Value | $2.58B | $84.90B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →